Medication info
Teddy M Met Extended-Release Tablet 20/1000 mg

Teddy M Met Extended-Release Tablet 20/1000 mg

Prescription medicationTabletOral
Ingredient · strength
Teneligliptin Hydrochloride Hydrate›26mg / 1 tabletMetformin Hydrochloride›1000mg / 1 tablet
Manufacturer / importer
Dongwha Pharm Co., Ltd.
Appearance
Pink oval extended-release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202201436 · Approved 2022.04.04 · Insurance code 642707230

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take one 20/1000mg extended-release tablet once daily. Patients taking the 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients who do not achieve adequate glycemic control with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current dose of metformin. For patients switching from combination therapy with teneligliptin and metformin to this medicine, the dose of this medicine may be started at the patient's current doses of teneligliptin and metformin. When switching from immediate-release metformin to an extended-release formulation, glycemic control should be closely monitored and the dose adjusted as appropriate. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from other glucose-lowering agents. Because this may cause changes in glycemic control, any change in the treatment of patients with type 2 diabetes should be made under careful monitoring. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Ingredients

Manufacturer
Dongwha Pharm Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication is used to help control blood sugar levels in patients with type 2 diabetes. It particularly assists in managing blood sugar levels more effectively when teneligliptin and metformin are administered together. When used in conjunction with dietary and exercise therapy, it can significantly aid in blood sugar management. This medication plays an important role in improving blood sugar levels and treating diabetes.

How to take

Adult dose

The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take one 20/1000mg extended-release tablet once daily. Patients taking the 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients who do not achieve adequate glycemic control with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current dose of metformin. For patients switching from combination therapy with teneligliptin and metformin to this medicine, the dose of this medicine may be started at the patient's current doses of teneligliptin and metformin. When switching from immediate-release metformin to an extended-release formulation, glycemic control should be closely monitored and the dose adjusted as appropriate. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from other glucose-lowering agents. Because this may cause changes in glycemic control, any change in the treatment of patients with type 2 diabetes should be made under careful monitoring. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Precautions

This medication is used to lower blood sugar; however, it can very rarely cause a serious condition known as lactic acidosis. Lactic acidosis occurs when lactic acid accumulates excessively in the body and can be fatal. Therefore, caution is required. Patients with moderate to severe renal impairment, acute kidney disease, heart failure, or liver dysfunction may be at risk when taking this medication. Additionally, if undergoing radiologic dye studies, this medication should be discontinued 48 hours prior to the test and can be resumed only after renal function has been confirmed to be normal. This medication is not suitable for patients with type 1 diabetes or diabetic ketoacidosis. Patients in a diabetic pre-coma state or those allergic to the active ingredients should also avoid taking this drug. In the event of severe infections, trauma, or before and after surgery, this medication should be temporarily discontinued, resuming only after the patient has recovered. The risk of hypoglycemia may increase when this medication is taken with other diabetes medications, so it is essential to be aware of the symptoms and management of hypoglycemia. Occasionally, acute pancreatitis, interstitial pneumonia, or skin allergy reactions may occur, so any unusual symptoms should be immediately reported to a healthcare provider. Pregnant or potentially pregnant women and nursing mothers are advised to avoid taking this medication. The elderly may experience decreased renal function, so regular kidney function tests should be conducted, and dosage adjustments may be necessary if needed. In cases of overdose, it is imperative to seek immediate medical attention for appropriate treatment, and blood dialysis may be used to remove the medication from the system. This medication must be kept out of the reach of children, and transferring it to other containers should be avoided. During treatment, it is recommended to avoid alcohol consumption and to regularly monitor blood vitamin B12 levels through blood tests. Finally, if severe abdominal pain, vomiting, difficulty breathing, skin rash, or other unusual symptoms occur during the use of this medication, immediate consultation with a doctor is advised.

Side effects

  • Severe lactic acidosis
  • severe hypoglycemia
  • hypoglycemia
  • constipation
  • intestinal obstruction
  • liver dysfunction
  • interstitial pneumonia
  • pemphigus
  • acute pancreatitis
  • dizziness
Show 152 more
  • abdominal distension
  • abdominal discomfort
  • nausea
  • abdominal pain
  • bloating
  • stomatitis
  • gastric polyps
  • colon polyps
  • duodenal ulcers
  • gastroesophageal reflux disease
  • diarrhea
  • anorexia
  • increased amylase
  • increased lipase
  • increased AST (GOT)
  • increased ALT (GPT)
  • increased GGT
  • increased ALP
  • proteinuria
  • ketonuria
  • potential hematuria
  • eczema
  • rash
  • itching
  • allergic dermatitis
  • arthralgia
  • increased CK (CPK)
  • elevated serum potassium levels
  • malaise
  • allergic rhinitis
  • elevated serum uric acid
  • peripheral edema
  • shingles
  • limb pain
  • upper abdominal pain
  • gastritis
  • upper respiratory infection
  • tremors
  • headache
  • weakness
  • hunger
  • fatigue
  • facial edema
  • dyspepsia
  • nausea
  • viral upper respiratory infection
  • rhinitis
  • cold sweat
  • diabetic retinopathy
  • vision loss
  • cough
  • pulmonary congestion
  • dyspnea
  • drug overdose
  • benign prostatic hyperplasia
  • headache
  • diarrhea
  • chronic gastritis
  • irritable bowel syndrome
  • fatigue
  • cerebral infarction
  • hyperglycemia
  • liver biopsy
  • decreased neutrophil count
  • blood sugar abnormalities
  • increased blood sugar
  • increased blood pressure
  • hepatic coma
  • lumbar spinal stenosis
  • intravertebral disc protrusion
  • intravertebral disc disorder
  • spinal ligament ossification
  • spinal foraminal stenosis
  • rotator cuff syndrome
  • bladder mass
  • ureteral calculi
  • urinary stones
  • coronary artery disease
  • unstable angina
  • gastroesophageal reflux disease
  • gastric polyps
  • gastritis
  • biliary obstruction
  • chronic cholecystitis
  • soft tissue infection
  • pneumonia
  • cataracts
  • depression
  • iliac artery stenosis
  • dizziness
  • benign prostatic hyperplasia
  • knee surgery
  • vomiting
  • abdominal pain
  • gastrointestinal motility disorder
  • decreased gastrointestinal motility
  • enteritis
  • toothache
  • anal rectal discomfort
  • acquired mixed hyperlipidemia
  • hypertriglyceridemia
  • vitamin D deficiency
  • abnormal weight gain
  • essential hypertension
  • orthostatic hypotension
  • white coat hypertension
  • bleeding
  • cough
  • insomnia
  • hives
  • hepatic coma
  • sensory disturbance
  • decreased sensation
  • tension headache
  • peripheral neuropathy
  • facial paralysis
  • sciatica
  • position-related dizziness
  • muscle weakness
  • lower back pain
  • limb pain
  • tendinitis
  • cervical pain
  • bone pain
  • osteoarthritis
  • osteoporosis
  • muscle cramps
  • foot deformity
  • hypertrophic osteoarthritis
  • bursitis
  • spinal osteoarthritis
  • postmenopausal osteoporosis
  • chronic bronchitis
  • goiter
  • hypercholesterolemia
  • arteriosclerosis
  • hypertension
  • ear pain
  • hearing loss
  • endolymphatic hydrops
  • anemia
  • food allergy
  • pressure ulcer
  • glaucoma
  • blurred vision
  • age-related macular degeneration
  • hyperthyroidism
  • hyperparathyroidism
  • ear pain
  • dizziness
  • iron deficiency anemia
  • food allergy

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture from entering. The recommended storage temperature is between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Pink oval extended-release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.